Event

June 2, 2021, Redeye Growth Day

We are participating in Redeye Growth Day 2021 on June 2. Helén Tuvesson, CEO, will present at 12.20. The presentation will be broadcasted live on https://www.redeye.se/events/808637/redeye-growth-day-2021

May 25, 2021, ABGSC Life Science Summit

Active Biotech presenting at the ABGSC Life Science Summit, May 25, 2021.

May 4, 2021, “Aktiedagen” (Swedish shareholders’ association, in Swedish)

February 9, 2022, Year-end report 2021

7-8 April 2021, Solebury Trout European Biotech Investor Days 2021

November 26, 2020, Active Biotech presenting at Redeye Life Science Day in Stockholm

November 24, 2020, Active Biotech’s virtual capital markets day

Active Biotech AB (publ) (ticker: ACTI) hereby invites analysts, investors and media to its virtual Capital Markets Day on November 24, 2020. Focus of the day will be on the new direction for the company with emphasis on its fully owned assets tasquinimod and laquinimod. Company management and international experts will present the current status […]

December 5-8, 2020, 62nd American Society of Hematology (ASH) Virtual Annual Meeting

November 30, 2020, Extraordinary general meeting in Active Biotech

September 10-12, 2019, Nordic Life Science Days, Malmö

June 3-6, 2019, BIO International, Philadelphia

May 4-10, 2019, AAN, Philadelphia

April 8-9, 2019, The European Conference on Neuroinflammation, London

April 4, 2019, Extraordinary shareholders’ meeting

February 6, 2020, Year-end report 2019

November 14, 2019, Interim report

August 8, 2019, Interim report

May 23, 2019, Annual General Meeting

April 25, 2019, Interim report

December 1–4, 2018, 60th ASH 2018 Annual Meeting & Exposition of the American Society of Hematology, San Diego, CA

September 10-12, 2018, NLSDays, Stockholm

August 29-30, 2018, LSX Nordic Congress 2018, Stockholm

June 4-7, 2018, BIO International Convention, Boston, USA

February 14, 2019, Year-end report 2018

August 9, 2018, Interim report

Annual General Meeting 2018

Read all information about the 2018 Annual General Meeting here.

Extraordinary shareholders’ meeting